Summary Table on Subpart D, 45 CFR 46 and 21 CFR 50: Additional DHHS Protections for Children Involved as Subjects in Research; Additional Safeguards for Children in Clinical Investigations (FDA) (Rev, 11 06, 1 07 - Ethical problems using children in clinical trials - Document - PDFSEARCH.IO

First Page	Meta Content
	Summary Table on Subpart D, 45 CFR 46 and 21 CFR 50: Additional DHHS Protections for Children Involved as Subjects in Research; Additional Safeguards for Children in Clinical Investigations (FDA) (Rev, 11/06, 1/07 Add to Reading List Document Date: 2012-02-24 19:42:33 Open Document File Size: 99,00 KB Share Result on Facebook IndustryTerm particular protocol / state law / local law / / MedicalCondition subject's disorder / subjects' disorder / / Organization FDA / Food and Drug Administration / International Rugby Board / DHHS’s Office for Human Research Protections / IRB / / Person Wards Children / / Position investigator / advocate / child advocate / Secretary / Commissioner / advocate for more than one child / / ProvinceOrState California / / Technology research protocol / particular protocol / / SocialTag Pharmacology Pharmaceutical sciences Research ethics Clinical pharmacology Food and Drug Administration United States Public Health Service Human subject research Institutional review board Ethical problems using children in clinical trials Clinical research

Summary Table on Subpart D, 45 CFR 46 and 21 CFR 50: Additional DHHS Protections for Children Involved as Subjects in Research; Additional Safeguards for Children in Clinical Investigations (FDA) (Rev, 11/06, 1/07Add to Reading List